London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Alphageddon it may be Polygon or a.n.other that is will to offer a CFD's... Either way we know Polygon won't stop now, they could be acting on behalf of some pharma company (buying stock cheaply) but the purchase of CFD's which do have a time period means they are most probably working on a sub 3 month timeframe. Not much longer now...
alkin - it would be interesting if Polygon have started buying shares again today. Dont forget from the last TR1 on 26th October that it showed they had stopped all share acquisition since at least 21st October - they had switched to paying for CFD's instead to presumably increase the leverage on their capital.
RM said he would need government support in ramping up manufacturing and the government have stated “ The UK government has announced an Antivirals Taskforce with the aim of identifying and deploying Covid-19 treatments as early as autumn.
The taskforce will search for the most promising novel antiviral medicines that can be easily taken at home, and to support their development through clinical trials, the government announced on 20 April. It will also look at opportunities to manufacture antiviral treatments in the UK.”
We also know through HHS that the USA are supporting manufacturing of promising drugs.
"At the end of the day, we are all just speculating unless of course you (generic) secretly work for one of the interested parties!" You are right of course Mact4, all speculation. BB's are a great source of information regarding investor sentiment. Many questions have been asked here and opinions sought - about how many shares are owned, stop losses in place, sell out points, deduced risk appetite, favoured scenarios, etc etc. All highly valuable information in certain hands. I'll just park that there for digesting later. GLA.
They don't need to raise funds. Enough cash in the bank until 2022 outside of P3, isn't that what RM said at interims? There's no cap and begging bowl scenario here. Assuming P3 delivers a drug to the current market (in grave need), there absolutely will be more than one interested party. Polygon's sudden lurch forward indicates that may be in play. I'd love to see multiple licence agreements in place with Synairgen getting a fat wadd of $$$ to take other treatments forward in the future. They are not the company they were 5 years ago and the market is chomping at the bit for more drugs to fill hungry pipelines.
Nasdaq initial listing will spell disaster for LTH's in the short and medium term (we would have to hold a lot longer for any real big gains if that were too happen). Just look at ARB and TILS - Complete sh*T show. It is not always the holy grail everyone alludes to. Defo do not want that it far too much of an uptick in risk.
I appreciate it can go both ways, but not something I think we need to even debate, let alone actually consider doing.
To be fair based on the Polygon interest and the ease at which SNG raised £80m last year, if they have the orders raising capital would be a breeze. That said if the USA was to be SNG's biggest market, it would hurt them being known more over there but I really hope we will have SNG over here, that is ultimately why I have invested in SNG. Nice though that the profit takers are making it cheap for Polygon and others to buy more shares, if you look at the data its obvious larger positions are being taken
Bruce, a listing on the Nasdaq would raise awareness of Synairgen and they would probably issue more shares. We know countries like to have a slice of the pie and if this course of action was taken, you would see a big upsurge in the SP on both sides of the pond.
If you add in those covid+ new cases where sng001 may help, then it can be assumed the demand for a drug that may save 70-80% of lives will be in very high demand. Maybe sng will be advised to pass it to a few major pharmaceutical companys to allow them to make it and dispense on a humankind endeavour with sng getting a royalty on each dose.
Perhaps or maybe the US govt might assist with some upfront costs, as they have done with another Covid therapeutic (sorry I am terrible at remembering names). There is also a case for another re-rating of SP - if SNG was listed on theNASDAQ. That could also help raise the necessary cash. Perhaps the more informed here might tell me if this idea has merit or is dead in the water!
I suspect, but I may be wrong, that synairgen will have a tie-up/jv up their sleeve whereby they will receive say £200m from a partner for about 25-40% of new synairgen shares and the money used to expedite manufacturing of drugs and devices. On top of this advance orders from USA for maybe up to USD500m for an upfront order. I suspect BungleBoris and his bunch of idjiots will be shut out as USA will take anything produced. My friend a Bioscientist reckons that upscaling the manufacturing of interferon would not be too much of a problem if sng have the readies. A deal such as that would in my opinion propel SP to over £6. Just my thoughts
The CFDs basically means Polygon are throwing the kitchen sink at this and the fact they are leveraged tells you how confident they are. Money is in short supply at the moment but I’ve followed their lead today with a modest top up.
alkin - I did a post a few days ago as to why I think Polygon secured the voting rights. The proceeds from the CFDs, once closed out, would be used to acquire the underlying shares from the other parties. They may have done it as it requires less upfront capital which may be in limited supply at the moment. This is what I suspect is happening and would explain why they have the voting rights.